William C. Koller

Active 1979–2021

101
Papers
18,776
Citations
89
h-index
101
i10-index

Citations

Citations per year for William C. Koller1980: 3 citations1981: 3 citations1982: 3 citations1983: 3 citations1984: 1 citations1985: 7 citations1986: 13 citations1987: 6 citations1988: 8 citations1989: 11 citations1990: 16 citations1991: 20 citations1992: 18 citations1993: 11 citations1994: 25 citations1995: 34 citations1996: 41 citations1997: 61 citations1998: 71 citations1999: 128 citations2000: 147 citations2001: 157 citations2002: 202 citations2003: 234 citations2004: 234 citations2005: 205 citations2006: 279 citations2007: 201 citations2008: 231 citations2009: 195 citations2010: 172 citations2011: 205 citations2012: 146 citations2013: 172 citations2014: 107 citations2015: 112 citations2016: 125 citations2017: 97 citations2018: 82 citations2019: 341 citations2020: 321 citations2021: 225 citations2022: 222 citations2023: 98 citations2024: 196 citations2025: 84 citations2026: 3 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,908 citing papers, 30.6% of this breakdownUnited Kingdom: 611 citing papers, 9.8% of this breakdownGermany: 407 citing papers, 6.5% of this breakdownItaly: 360 citing papers, 5.8% of this breakdownCanada: 336 citing papers, 5.4% of this breakdownSpain: 240 citing papers, 3.8% of this breakdownChina: 224 citing papers, 3.6% of this breakdownNetherlands: 198 citing papers, 3.2% of this breakdownFrance: 193 citing papers, 3.1% of this breakdownAustralia: 161 citing papers, 2.6% of this breakdownSweden: 137 citing papers, 2.2% of this breakdownJapan: 111 citing papers, 1.8% of this breakdown
0%30.6%Other 21.6%

Fields

  • Medicine73.9%
  • Neuroscience8.2%
  • Biochemistry, Genetics and Molecular Biology7.5%
  • Health Professions2.6%
  • Environmental Science2.2%
  • Psychology1.4%
  • Other4.2%

Topics

  • Parkinson's Disease Mechanisms and Treatments19.4%
  • Neurological disorders and treatments15.7%
  • Genetic Neurodegenerative Diseases3.8%
  • Botulinum Toxin and Related Neurological Disorders3.5%
  • Parkinson's Disease and Spinal Disorders2.4%
  • Transcranial Magnetic Stimulation Studies2.4%
  • Other52.8%

Coauthors

All papers

Open in search
  1. Variable expression of Parkinson's disease

    Authors: , , , , , , , , , , , , , - Neurology 1990 cited by 1,279

  2. International multicenter pilot study of the first comprehensive self‐completed nonmotor symptoms questionnaire for Parkinson's disease: The NMSQuest study

    Authors: , , , , , , , , , , , , , , , , , , , , , - Movement Disorders 2006 cited by 1,100

  3. High‐frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor

    Authors: , , , , , , , , , , , , , , , , - Annals of Neurology 1997 cited by 482

  4. Long‐term safety and efficacy of unilateral deep brain stimulation of the thalamus in essential tremor

    Authors: , , , , - Movement Disorders 2001 cited by 298

  5. The diagnosis of manganese-induced parkinsonism

    Authors: , - NeuroToxicology 2005 cited by 234

  6. A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor

    Authors: , , , , , , , , , , , , , , - Neurology 2001 cited by 232

  7. An R5L τ mutation in a subject with a progressive supranuclear palsy phenotype

    Authors: , , , , , , , , , , - Annals of Neurology 2002 cited by 196

  8. Deep brain stimulation for essential tremor

    Authors: , , , , , - Neurology 1996 cited by 174

  9. Apolipoprotein E controls the risk and age at onset of Parkinson disease

    Authors: , , , , , , , , , , , , , , , , , , , - Neurology 2004 cited by 145

  10. An algorithm (decision tree) for the management of Parkinson’s disease (2001):

    Authors: , , - Neurology 2001 cited by 712

  11. PAINFUL PARKINSON'S DISEASE

    Authors: , , , - The Lancet 1986 cited by 213

  12. Acute and chronic effects of propranolol and primidone in essential tremor

    Authors: , - Neurology 1989 cited by 196

  13. Dose–effect relationships between manganese exposure and neurological, neuropsychological and pulmonary function in confined space bridge welders

    Authors: , , , , , , , , , , , , - Occupational and Environmental Medicine 2006 cited by 262

  14. Neuropsychological and quality of life outcome after thalamic stimulation for essential tremor

    Authors: , , , , , , , - Neurology 1999 cited by 140

  15. Predictors of multi-domain cognitive decline following DBS for treatment of Parkinson's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Claudia S. Moy, Paul A. Sheehy, Timothy J. O’Leary, Grant D. Huang, Louis D. Fiore, Robert Hall, Kevin T. Stroupe, Kim J. Burchiel, Kenneth A. Follett, Carol L. Fye, Crystal L. Harris, Jill Heemskerk, Kwan Hur, William C. Koller, William J. Marks, Claudia S. Moy, Rajesh Pahwa, Domenic J. Reda, Johannes Rothlind, Oren Sagher, Paul A. Sheehy, Matthew Stern, Frances M. Weaver, Roy A.E. Bakay, Rick Chappell, Robert A. Hart, Robert G. Holloway, George P. McCabe, Margaret Schenkman, Jamal Taha, Julia Buckelew, Carol L. Fye, Marilyn Garin, Sharon Matzek, Donna Smith, Jeff M. Bronstein, John E. Duda, Penelope Hogarth, Kathryn L. Holloway, Stacy Horn, Eugene C. Lai, William J. Marks, Ali Samii, Farah Atassi, Cecilia Bukola Bello, Lisette Bunting‐Perry, Tina Conn, Alice Cugley, Nanette Eubank, Linda Fincher, Romay Franks, T. B. Harris, Mariann Haselman, Susan Heath, Miriam Hirsch, Virginia Janovsky, Elaine Lanier, Mary Lloyd, Susan Loehner, Susan O’Connor, Ligaya Ordonez, Heather Maccarone, Kelli Massey-Makhoul, Mary Matthews, Elizabeth Meyn, Keiko Mimura, W.G. Morrow, Tammy Searles, Jamye Valotta, U. S. Vasthare and 41 more - Parkinsonism & Related Disorders 2021 cited by 15

  16. Mitochondrial Polymorphisms Significantly Reduce the Risk of Parkinson Disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The American Journal of Human Genetics 2003 cited by 537

  17. The relationship of essential tremor to other movement disorders: Report on 678 patients

    Authors: , , , - Annals of Neurology 1994 cited by 301

  18. Weight Change and Body Composition in Patients With Parkinson's Disease

    Authors: , , , , - Journal of the American Dietetic Association 1995 cited by 172

  19. Benztropine versus clozapine for the treatment of tremor in Parkinson's disease

    Authors: , , , , , - Neurology 1997 cited by 104

  20. Parkinsonism due to manganism in a welder: Neurological and neuropsychological sequelae

    Authors: , , - NeuroToxicology 2006 cited by 99

  21. Mechanism of action of dopaminergic agents in Parkinson's disease

    Authors: , - Neurology 1998 cited by 94

  22. Effect of levodopa treatment for parkinsonism in welders

    Authors: , , - Neurology 2004 cited by 93

  23. Clinical expression of essential tremor: Effects of gender and age

    Authors: , , , , - Movement Disorders 1997 cited by 163

  24. Efficacy of primidone in essential tremor

    Authors: , - Neurology 1986 cited by 140